These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 19800084

  • 1. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
    Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN, Kong WJ, Jiang JD.
    Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
    [Abstract] [Full Text] [Related]

  • 2. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
    Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD.
    Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L.
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [Abstract] [Full Text] [Related]

  • 4. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y, Li Y, Wang Y, Wen Y, Sun C.
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [Abstract] [Full Text] [Related]

  • 5. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor.
    Wang YX, Wang YP, Zhang H, Kong WJ, Li YH, Liu F, Gao RM, Liu T, Jiang JD, Song DQ.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6004-8. PubMed ID: 19800225
    [Abstract] [Full Text] [Related]

  • 7. Berberine inhibits PTP1B activity and mimics insulin action.
    Chen C, Zhang Y, Huang C.
    Biochem Biophys Res Commun; 2010 Jul 02; 397(3):543-7. PubMed ID: 20515652
    [Abstract] [Full Text] [Related]

  • 8. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
    Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, Hu LH, Li J, Ye JM.
    Diabetes; 2008 May 02; 57(5):1414-8. PubMed ID: 18285556
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
    Strowig SM, Raskin P.
    Diabetes Obes Metab; 2005 Nov 02; 7(6):633-41. PubMed ID: 16219007
    [Abstract] [Full Text] [Related]

  • 10. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y, DeFronzo RA.
    Diabetes Obes Metab; 2008 Dec 02; 10(12):1204-11. PubMed ID: 18476983
    [Abstract] [Full Text] [Related]

  • 11. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP.
    Diabetes Obes Metab; 2007 Mar 02; 9(2):186-93. PubMed ID: 17300594
    [Abstract] [Full Text] [Related]

  • 12. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P.
    Clin Endocrinol (Oxf); 2006 Dec 02; 65(6):722-8. PubMed ID: 17121522
    [Abstract] [Full Text] [Related]

  • 13. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 02; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 14. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ, White RD.
    J Fam Pract; 2007 Aug 02; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase D activation stimulates the transcription of the insulin receptor gene.
    Zhang H, Kong WJ, Shan YQ, Song DQ, Li Y, Wang YM, You XF, Jiang JD.
    Mol Cell Endocrinol; 2010 Dec 15; 330(1-2):25-32. PubMed ID: 20674666
    [Abstract] [Full Text] [Related]

  • 16. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, Ji G.
    Eur J Pharmacol; 2011 Oct 15; 668(3):467-71. PubMed ID: 21839075
    [Abstract] [Full Text] [Related]

  • 17. Elevated circulating vaspin levels were decreased by rosiglitazone therapy in T2DM patients with poor glycemic control on metformin alone.
    Zhang L, Li L, Yang M, Liu H, Yang G.
    Cytokine; 2011 Nov 15; 56(2):399-402. PubMed ID: 21802961
    [Abstract] [Full Text] [Related]

  • 18. Borapetoside C from Tinospora crispa improves insulin sensitivity in diabetic mice.
    Ruan CT, Lam SH, Chi TC, Lee SS, Su MJ.
    Phytomedicine; 2012 Jun 15; 19(8-9):719-24. PubMed ID: 22579212
    [Abstract] [Full Text] [Related]

  • 19. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X, Yan J, Shen Y, Tang K, Yin J, Zhang Y, Yang D, Liang H, Ye J, Weng J.
    PLoS One; 2011 Feb 03; 6(2):e16556. PubMed ID: 21304897
    [Abstract] [Full Text] [Related]

  • 20. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
    Di S, Han L, An X, Kong R, Gao Z, Yang Y, Wang X, Zhang P, Ding Q, Wu H, Wang H, Zhao L, Tong X.
    J Ethnopharmacol; 2021 Aug 10; 276():114180. PubMed ID: 33957209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.